MSB 3.83% $1.26 mesoblast limited

Ann: Biotech Showcase 2023 Presentation in San Francisco, page-180

  1. 15,482 Posts.
    lightbulb Created with Sketch. 5576

    Most countries around the world seem to have Ischaemic Heart Disease at the top or at least 2nd in the leading causes of death but hey do take your time FDA in relation to the Rexlemestrocel-L feedback on how to proceed with this indication ?


    https://www.cdc.gov/nchs/fastats/leading-causes-of-death.htm

    upload_2023-1-23_15-48-38.png



    https://www.ons.gov.uk/peoplepopula...andwales/december2022#leading-causes-of-death

    upload_2023-1-23_15-51-45.png



    https://www.healthdata.org/india

    upload_2023-1-23_15-59-51.png



    https://www.aihw.gov.au/reports/lif...in-australia/contents/leading-causes-of-death

    upload_2023-1-23_15-53-20.png
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.26
Change
-0.050(3.83%)
Mkt cap ! $1.432B
Open High Low Value Volume
$1.27 $1.30 $1.17 $21.32M 17.21M

Buyers (Bids)

No. Vol. Price($)
4 5460 $1.25
 

Sellers (Offers)

Price($) Vol. No.
$1.26 978 1
View Market Depth
Last trade - 16.10pm 24/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.